JORDAN LINDEKENS: Open Payments
NPI 1871220152 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,056 in 29 payments from 10 companies in 2025. Trend: 2023 $415 · 2024 $864 · 2025 $1,056
Food & beverage: $1,056
| Company | Payments | Amount |
|---|---|---|
| Paragonix Technologies, Inc. | 1 | $297 |
| CVRx, Inc. | 4 | $207 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $161 |
| AstraZeneca Pharmaceuticals LP | 7 | $138 |
| SCPHARMACEUTICALS INC. | 3 | $98 |
| Alnylam Pharmaceuticals Inc. | 2 | $63 |
| PFIZER INC. | 2 | $31 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| BridgeBio Pharma, Inc. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
Products named: Barostim Neo System, JARDIANCE, WAINUA, FUROSCIX, AMVUTTRA, LOKELMA, VYNDAQEL, VERQUVO.
Industry payments across NY — which companies pay providers there.
